Concepts (91)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Activin Receptors, Type I | 1 | 2024 | 33 | 0.860 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2024 | 614 | 0.770 |
Why?
|
| Small Molecule Libraries | 4 | 2024 | 132 | 0.600 |
Why?
|
| Macrocyclic Compounds | 1 | 2015 | 14 | 0.440 |
Why?
|
| Furans | 1 | 2015 | 28 | 0.440 |
Why?
|
| Ketones | 1 | 2015 | 26 | 0.440 |
Why?
|
| Drug Discovery | 2 | 2024 | 178 | 0.350 |
Why?
|
| Activin Receptors, Type II | 1 | 2024 | 30 | 0.220 |
Why?
|
| Contraceptive Agents, Male | 1 | 2024 | 34 | 0.200 |
Why?
|
| Contraception | 1 | 2024 | 61 | 0.200 |
Why?
|
| Molecular Structure | 4 | 2021 | 313 | 0.190 |
Why?
|
| Gold | 1 | 2023 | 54 | 0.190 |
Why?
|
| Metal Nanoparticles | 1 | 2023 | 55 | 0.190 |
Why?
|
| Rotaxanes | 1 | 2021 | 1 | 0.180 |
Why?
|
| Calixarenes | 1 | 2021 | 1 | 0.180 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2021 | 33 | 0.180 |
Why?
|
| Protease Inhibitors | 1 | 2021 | 95 | 0.170 |
Why?
|
| Biofilms | 1 | 2021 | 92 | 0.160 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2021 | 177 | 0.160 |
Why?
|
| Brucella abortus | 1 | 2019 | 5 | 0.160 |
Why?
|
| DNA | 1 | 2024 | 1406 | 0.150 |
Why?
|
| Structure-Activity Relationship | 4 | 2024 | 552 | 0.140 |
Why?
|
| Stereoisomerism | 2 | 2015 | 109 | 0.140 |
Why?
|
| Tubulin | 2 | 2014 | 76 | 0.130 |
Why?
|
| Host-Pathogen Interactions | 1 | 2019 | 253 | 0.130 |
Why?
|
| Stress, Physiological | 1 | 2019 | 261 | 0.130 |
Why?
|
| bcl-2 Homologous Antagonist-Killer Protein | 1 | 2017 | 14 | 0.130 |
Why?
|
| Mitochondrial Membranes | 1 | 2017 | 32 | 0.130 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2017 | 64 | 0.130 |
Why?
|
| DNA Damage | 1 | 2019 | 517 | 0.120 |
Why?
|
| Neuroprotective Agents | 1 | 2017 | 162 | 0.110 |
Why?
|
| Macrophages | 1 | 2019 | 661 | 0.110 |
Why?
|
| Cyclization | 1 | 2015 | 16 | 0.110 |
Why?
|
| Aldehydes | 1 | 2015 | 27 | 0.110 |
Why?
|
| Ethers, Cyclic | 1 | 2014 | 13 | 0.110 |
Why?
|
| Epothilones | 1 | 2014 | 3 | 0.110 |
Why?
|
| Tubulin Modulators | 1 | 2014 | 11 | 0.110 |
Why?
|
| Macrolides | 1 | 2014 | 32 | 0.110 |
Why?
|
| Sirolimus | 1 | 2015 | 232 | 0.100 |
Why?
|
| Biological Products | 1 | 2014 | 143 | 0.090 |
Why?
|
| Signal Transduction | 1 | 2024 | 4682 | 0.090 |
Why?
|
| Apoptosis | 1 | 2017 | 1834 | 0.080 |
Why?
|
| Proteins | 1 | 2014 | 1014 | 0.070 |
Why?
|
| Binding Sites | 2 | 2022 | 1141 | 0.060 |
Why?
|
| Protein Binding | 2 | 2022 | 1659 | 0.050 |
Why?
|
| Blood-Testis Barrier | 1 | 2024 | 14 | 0.050 |
Why?
|
| Humans | 8 | 2024 | 130525 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2021 | 2902 | 0.050 |
Why?
|
| Animals | 6 | 2024 | 33856 | 0.050 |
Why?
|
| Carbohydrates | 1 | 2023 | 34 | 0.050 |
Why?
|
| Lectins, C-Type | 1 | 2023 | 69 | 0.050 |
Why?
|
| Sialic Acids | 1 | 2022 | 17 | 0.050 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 2022 | 23 | 0.050 |
Why?
|
| Testis | 1 | 2024 | 390 | 0.050 |
Why?
|
| Ligands | 1 | 2023 | 485 | 0.040 |
Why?
|
| Polyelectrolytes | 1 | 2021 | 1 | 0.040 |
Why?
|
| Molecular Conformation | 1 | 2021 | 96 | 0.040 |
Why?
|
| Hemolysis | 1 | 2021 | 89 | 0.040 |
Why?
|
| Genetic Engineering | 1 | 2021 | 160 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2021 | 578 | 0.040 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2022 | 216 | 0.040 |
Why?
|
| Alkylation | 1 | 2019 | 10 | 0.040 |
Why?
|
| Vacuoles | 1 | 2019 | 30 | 0.040 |
Why?
|
| Brucellosis | 1 | 2019 | 19 | 0.040 |
Why?
|
| RAW 264.7 Cells | 1 | 2019 | 47 | 0.040 |
Why?
|
| Mice | 3 | 2024 | 18236 | 0.040 |
Why?
|
| Virus Replication | 1 | 2021 | 604 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2021 | 847 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2021 | 1059 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2021 | 1611 | 0.030 |
Why?
|
| Escherichia coli | 1 | 2023 | 991 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2017 | 65 | 0.030 |
Why?
|
| Permeability | 1 | 2017 | 119 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2017 | 148 | 0.030 |
Why?
|
| Glutamic Acid | 1 | 2017 | 193 | 0.030 |
Why?
|
| Liposomes | 1 | 2017 | 196 | 0.030 |
Why?
|
| DNA Repair | 1 | 2019 | 576 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2017 | 716 | 0.030 |
Why?
|
| Amino Alcohols | 1 | 2015 | 3 | 0.030 |
Why?
|
| Pyrans | 1 | 2015 | 6 | 0.030 |
Why?
|
| Pipecolic Acids | 1 | 2015 | 10 | 0.030 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2014 | 43 | 0.030 |
Why?
|
| 14-3-3 Proteins | 1 | 2014 | 57 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2021 | 3714 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2017 | 1319 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2014 | 167 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2014 | 159 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2019 | 1080 | 0.020 |
Why?
|
| Neurons | 1 | 2017 | 2009 | 0.020 |
Why?
|
| Male | 2 | 2024 | 64514 | 0.010 |
Why?
|
| Female | 1 | 2017 | 70422 | 0.000 |
Why?
|